This report examines the current U.S. regulatory system for GE crops, compares it with those of major trading partners, and considers the effects it has on agricultural biotechnology.

This Issue Paper identifies the nature of gene flow and discusses the relatively limited situations in which it is likely to cause economic problems in the production of commercial biotech crops.